| |
 |
Editorial [Hot Topic: Perspectives in Psychopharmacological Neuroimaging (Executive Editor: Paolo Fusar-Poli)]
|
| |
|
pp.2533-2534 (2) Author: Paolo Fusar- Poli
|
| |
|
|
| |
 |
The Effects of Antipsychotics on the Brain: What Have We Learnt from Structural Imaging of Schizophrenia? – A Systematic Review
|
| |
|
pp.2535-2549 (15) Authors: R. Smieskova, P. Fusar-Poli, P. Allen, K. Bendfeldt, R. D. Stieglitz, J. Drewe, E. W. Radue, P. K. McGuire, A. Riecher-Rossler, S. J. Borgwardt
|
| |
|
|
| |
 |
Mechanisms Underlying Psychosis and Antipsychotic Treatment Response in Schizophrenia: Insights from PET and SPECT Imaging
|
| |
|
pp.2550-2559 (10) Authors: O. D. Howes, A. Egerton, V. Allan, P. McGuire, P. Stokes, S. Kapur
|
| |
|
|
| |
 |
Functional Imaging as a Tool to Investigate the Relationship between Genetic Variation and Response to Treatment with Antipsychotics
|
| |
|
pp.2560-2572 (13) Authors: A. Di Giorgio, F. Sambataro, A. Bertolino
|
| |
|
|
| |
 |
What do ERPs and ERFs Reveal About the Effect of Antipsychotic Treatment on Cognition in Schizophrenia?
|
| |
|
pp.2573-2593 (21) Authors: M. Korostenskaja, S. Kahkonen
|
| |
|
|
| |
 |
Imaging the Glutamate System in Humans: Relevance to Drug Discovery for Schizophrenia
|
| |
|
pp.2594-2602 (9) Author: James M. Stone
|
| |
|
|
| |
 |
Imaging the Neural Effects of Cannabinoids: Current Status and Future Opportunities for Psychopharmacology
|
| |
|
pp.2603-2614 (12) Authors: S. Bhattacharyya, J. A. Crippa, R. Martin-Santos, T. Winton-Brown, P. Fusar-Poli
|
| |
|
|
| |
 |
Connecting the Brain and New Drug Targets for Schizophrenia
|
| |
|
pp.2615-2631 (17) Authors: H. C. Whalley, J. D. Steele, P. Mukherjee, L. Romaniuk, A. M. McIntosh, J. Hall, S. M. Lawrie
|
| |
|
|
| |
 |
Myelination in Bipolar Patients and the Effects of Mood Stabilizers on Brain Anatomy
|
| |
|
pp.2632-2636 (5) Authors: Paolo Brambilla, Marcella Bellani, Ping-Hong Yeh, Jair C. Soares
|
| |
|
|
| |
 |
Neuroimaging and Genetics of Antidepressant Response to Sleep Deprivation: Implications for Drug Development
|
| |
|
pp.2637-2649 (13) Authors: Francesco Benedetti, Enrico Smeraldi
|
| |
|
|